translate
English
پارسی
English
Englishپارسی
English
Englishپارسی
EnglishپارسیEnglishپارسیRobinhood (HOOD) posted EPS of $0.66 vs $0.60 expected (+10.00% surprise) but revenue of $1.28B vs $1.34B expected (-4.48% surprise). Shares were down ~1.04% (last $85.66) and fell ~6.41% after hours (to $80.11), with market cap around $77.1B—suggesting investors are focused on top-line momentum and outlook.
Marriott (MAR) reported EPS of $2.58 vs $2.61 expected (-1.15% surprise) while revenue was $6.69B vs $6.67B expected (+0.30% surprise). Shares were up ~8.50% (last $359.35) and +0.54% in extended hours (to $361.30), with market cap near $96.88B—implying the market liked guidance and demand commentary despite the slight EPS miss.
Spotify (SPOT) posted EPS of $4.43 vs $2.85 expected (+55.44% surprise) and revenue of $4.53B vs $4.52B expected (+0.22% surprise). Shares jumped ~14.75% (last $476.01) and were +0.37% in extended hours (to $477.79), with market cap around $99.45B—investors are likely responding to profitability/margins and guidance tone.
S&P Global (SPGI) reported EPS of $4.30 vs $4.32 expected (-0.46% surprise) and revenue of $3.92B vs $3.90B expected (+0.51% surprise). Shares were down ~9.71% (last $401.08) with +0.26% in extended hours (to $402.11), and market cap is about $121.96B—a move that typically points to guidance, pricing, and growth assumptions being the real driver.
Welltower (WELL) posted EPS of $0.14 vs $0.56 expected (-75.00% surprise) but revenue of $3.18B vs $2.85B expected (+11.58% surprise). Shares were up ~1.82% (last $200.84) and +1.29% in extended hours (to $203.44), with market cap near $137.53B—the market will likely focus on FFO/NOI detail and forward outlook given the EPS shortfall.
Gilead (GILD) reported EPS of $1.86 vs $1.85 expected (+0.54% surprise) and revenue of $7.93B vs $7.68B expected (+3.26% surprise). Shares were down ~2.93% (last $147.23) and -3.00% in extended hours (to $142.81), with market cap around $182.75B—suggesting investors are likely grading guidance and product-level momentum.
AstraZeneca (AZN) posted EPS of $2.12 vs $1.06 expected (+100.00% surprise) and revenue of $15.5B vs $15.48B expected (+0.13% surprise). Shares were up ~2.77% (last $193.22) with -0.39% in extended hours (to $192.65), and market cap is about $301.5B—attention now typically turns to guidance and pipeline/launch commentary.
Coca-Cola (KO) reported EPS of $0.58 vs $0.56 expected (+3.57% surprise) but revenue of $11.8B vs $12.04B expected (-1.99% surprise). Shares were down ~1.48% (last $76.82) with +0.15% in extended hours (to $76.93), and market cap is about $335.4B—so the market’s focus likely shifts to volume/pricing mix and forward guidance.
U.S. equity futures opened Monday with modest gains across the board, signaling a steady, mildly constructive tone at the start of the week.
The move is incremental rather than decisive—more “cautious optimism” than a full risk-on surge—suggesting markets are opening the week balanced and waiting for catalysts.
Asian equities kicked off Monday in clear risk-on mode, with all major benchmarks posting gains and Japan’s Nikkei 225 decisively outperforming.
The tone at the start of the week is broadly constructive across the region, with leadership from Japan and solid follow-through in Greater China and Hong Kong.
Biogen (BIIB) reported EPS of $1.99 vs $1.61 expected (+23.60% surprise) and revenue of $2.28B vs $2.21B expected (+3.17% surprise), delivering a clear beat on both earnings and sales. The stock was up ~8.45% around the time shown (near $201.02) but down ~3.66% in extended hours (around $193.82), with a market cap near $29.58B—a setup that typically puts the spotlight on forward guidance, product/demand commentary, and any pipeline updates that could affect 2026 growth.
Philip Morris (PM) posted EPS of $1.70, in line with the $1.70 forecast (0.00% surprise) and revenue of $10.4B vs $10.39B expected (+0.10% surprise). Shares were up ~0.40% (around $182.73) but down ~0.43% in extended hours (around $182.03), with a market cap near $283.53B. With results essentially on-target, the market typically pivots to guidance, volume/pricing trends, and any updates on smoke-free product momentum and margin discipline.